SLC30A8 and diabetic kidney disease: In conclusion, the current study for the first time demonstrates that ZnT8 has the protective effects against EMT-tubulointerstitial fibrosis though the restrain of TGF-β1/Smads signaling activation, which may provide a potential novel strategy for the prevention and treatment of EMT-tubulointerstitial fibrosis in DKD.